" /> Histiocytosis-lymphadenopathy plus syndrome - CISMeF





Preferred Label : Histiocytosis-lymphadenopathy plus syndrome;

Type : Phenotype, molecular basis known;

Alternative titles and symbols : Histiocytosis with joint contractures and sensorineural deafness; SHML; Sinus histiocytosis and massive lymphadenopathy; PHID; H syndrome; Faisalabad histiocytosis; Hyperpigmentation, cutaneous, with hypertrichosis, hepatosplenomegaly, heart anomalies, and hypogonadism with or without hearing loss; HJCD; Histiocytosis and lymphadenopathy with or without cutaneous, cardiac, and/or endocrine features, joint contractures, and/or deafness; Pigmented hypertrichosis with insulin-dependent diabetes mellitus; Rosai-dorfman disease, familial;

Description : The histiocytosis-lymphadenopathy plus syndrome comprises features of 4 histiocytic disorders previously thought to be distinct: Faisalabad histiocytosis (FHC), sinus histiocytosis with massive lymphadenopathy (SHML), H syndrome, and pigmented hypertrichosis with insulin-dependent diabetes mellitus syndrome (PHID). FHC described an autosomal recessive disease involving joint deformities, sensorineural hearing loss, and subsequent development of generalized lymphadenopathy and swellings in the eyelids that contain histiocytes (summary by Morgan et al., 2010).;

Inheritance : Autosomal recessive;

Molecular basis : Caused by mutation in the solute carrier family 29 (nucleoside transporter), member 3 gene (SLC29A3, 612373.0001);

Laboratory abnormalities : Elevated inflammatory markers;

Prefixed ID : #602782;

Details


You can consult :


Nous contacter.
18/05/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.